A new form of drug drastically improves survival rates of pre-menopausal women with the most common type of breast cancer, researchers said on Saturday, citing the results of an international clinical trial. The findings, presented at the annual meeting of the American Society of Clinical Oncology in Chicago, showed that the addition of cell-cycle inhibitor […]CONTINUE READING >>>
New breast cancer drug found to boost survival rates by 30 percent
